azides has been researched along with 3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (37.50) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Coleman, JW; Park, BK; Tingle, MD; Yeung, JH | 1 |
Lee, JD; Shih, JC | 1 |
Bolger, MB; Lee, JD; Ransom, RW; Shih, JC | 1 |
Boulet, LP; Bousquet, J; Carlsheimer, A; Magnussen, H; Martinez-Aguilar, NE; Peters, MJ; Quiralte, J | 1 |
Bialy, L; Dryden, DM; Rowe, BH; Spooner, CH; Stickland, MK; Tjosvold, L; Vandermeer, B; Wong, K | 1 |
Chen, HN; Chen, SC; Chin, YY; Chu, YT; Hung, CH; Kuo, CH; Lam, KP; Lee, MS; Tok, TS; Wang, WL | 1 |
Kardos, P | 1 |
Patti, F | 1 |
1 review(s) available for azides and 3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole
Article | Year |
---|---|
Exercise-induced bronchoconstriction and asthma.
Topics: Adrenergic beta-Agonists; Asthma, Exercise-Induced; Azides; Humans; Male; Randomized Controlled Trials as Topic; Serotonin | 2010 |
2 trial(s) available for azides and 3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole
Article | Year |
---|---|
Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Adult; Aged; Aged, 80 and over; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Azides; Budesonide; Child; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluticasone-Salmeterol Drug Combination; Formoterol Fumarate; Hospitalization; Humans; Lung; Male; Middle Aged; Proportional Hazards Models; Respiratory Function Tests; Serotonin; Treatment Outcome | 2007 |
Budesonide/formoterol maintenance and reliever therapy versus free-combination therapy for asthma: a real-life study.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Anti-Asthmatic Agents; Asthma; Azides; Budesonide; Drug Therapy, Combination; Ethanolamines; Female; Formoterol Fumarate; Germany; Humans; Male; Middle Aged; Prevalence; Quality of Life; Risk Factors; Self Administration; Serotonin; Treatment Outcome | 2013 |
5 other study(ies) available for azides and 3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole
Article | Year |
---|---|
Enzyme-linked immunosorbent assay (ELISA) for detection of antibodies to protein-reactive drugs and metabolites: criteria for identification of antibody activity. Detection and hapten specificity of anti-DNP, anti-captopril and anti-sulphanilamidobenzoic
Topics: Animals; Antibodies; Antibody Specificity; Azides; Binding, Competitive; Captopril; Dinitrobenzenes; Enzyme-Linked Immunosorbent Assay; Epitopes; Haptens; Nitrobenzenes; Proteins; Rabbits; Serotonin | 1986 |
Evidence for two conformational states of 5-hydroxytryptamine carrier in rat cortical synaptosomes.
Topics: Animals; Azides; Cerebral Cortex; Fluoxetine; In Vitro Techniques; Kinetics; Male; Molecular Conformation; Photolysis; Propylamines; Rats; Rats, Inbred Strains; Serotonin; Sodium; Synaptosomes | 1987 |
Photoinactivation of serotonin uptake by an arylazido derivative of 5-hydroxytryptamine.
Topics: Affinity Labels; Alanine; Animals; Azides; Binding, Competitive; Biological Transport; Cerebral Cortex; Fenfluramine; Kinetics; Male; p-Chloroamphetamine; Photochemistry; Rats; Serotonin; Serotonin Antagonists; Spectrum Analysis | 1985 |
Inhibitory effects of albuterol and fenoterol on RANTES and IP-10 expression in bronchial epithelial cells.
Topics: Albuterol; Asthma; Azides; Bronchi; Cell Line; Chemokine CCL5; Chemokine CXCL10; Cyclic AMP; Epithelial Cells; Fenoterol; Gene Expression Regulation; Humans; MAP Kinase Signaling System; Poly I-C; Propanolamines; Serotonin | 2011 |
Standardised Frankincense extract: new possible therapeutic option for patients with relapsing-remitting multiple sclerosis.
Topics: Azides; Frankincense; Humans; Interferon-beta; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Serotonin | 2018 |